Fidelity Manager Rides High on Biotech

Fidelity Manager Rides High on Biotech

Rajiv Kaul, who has posted average annual returns of more than 30 percent over the last three years managing the Fidelity Select Biotechnology Portfolio, says a bubble may be forming in his sector and investors should be selective in picking these stocks. Photograph: Nigel Parry/Bloomberg Markets